India  

SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News

Video Credit: Oneindia - Duration: 01:31s - Published
SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News

SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News

The Subject Expert Committee of the Central Drugs Standard Control Organisation did not approve Serum Institute of India’s request to allow clinical trials of its second Covid vaccine in children.

#SII #CDSCO #Covovax


You Might Like


💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to..
IndiaTimes

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Terry Reintke: Despite setbacks EU's Green Deal can be saved [Video]

Terry Reintke: Despite setbacks EU's Green Deal can be saved

With an unprecedented breaththrough the Greens were among the surprise winners of the last European elections. Their ambitious climate agenda won over many voters. But Covid-19, the war in Ukraine, inflation and soaring energy costs have all taken heavy toll on the movement's popularity

Credit: euronews (in English)    Duration: 20:00Published
AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]

AstraZeneca requests European authorisation of Covid vaccine be pulled

AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.

Credit: euronews (in English)    Duration: 00:35Published

AstraZeneca starts worldwide withdrawal of COVID vaccine

AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy.
Sky News
AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering it unusable. This decision marks a significant development in the global vaccination effort against Covid-19. #COVID19 #Astrazeneca #COVIDVaccine #Covishield #Worldnews #Indianews #UKCourt #Oneindia #Oneindianews ~PR.320~ED.102~

Credit: Oneindia    Duration: 05:11Published

Related videos from verified sources

Covid vaccine for children likely by September, says AIIMS chief | Oneindia News [Video]

Covid vaccine for children likely by September, says AIIMS chief | Oneindia News

AIIMS chief Dr Randeep Guleria in an interview to a tv channel said tht covid 19 vaccines for children in india are likely to be introduced by the end of september. He said India might have more than 1..

Credit: Oneindia     Duration: 02:16Published
Covid-19: 16 European countries recognise Covishield| Adar Poonawalla hails good news| Oneindia News [Video]

Covid-19: 16 European countries recognise Covishield| Adar Poonawalla hails good news| Oneindia News

Adar Poonawalla, Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII), on Saturday said it was good news that Covishield - India-made version of AstraZeneca Covid vaccine - is..

Credit: Oneindia     Duration: 02:18Published
Rahul Gandhi's message to dissidents: Run to RSS, we don't need you| Oneindia News [Video]

Rahul Gandhi's message to dissidents: Run to RSS, we don't need you| Oneindia News

The Union Health Ministry on Friday raised concern about the rise in Covid-19 cases in several districts in India and cautioned that children may also be susceptible to the infection. India is yet to..

Credit: Oneindia     Duration: 02:22Published